Sponsored session - Fight with care: The power of cancer supportive skin care – covering the patient’s dermatologic needs

Sponsored session - Fight with care: The power of cancer supportive skin care – covering the patient’s dermatologic needs

Plenary E (level +3)
Sponsored session

Information

Session organised by La Roche-Posay

Chaired by Steven McIntosh, Macmillan Cancer Support (United Kingdom)

Presentations:

1. Panel discussion - Delphine Kerob, La Roche Posay Laboratoire Dermatologique (France)

Theme
6. People living with cancer
Objectives
Supportive care in cancer is the prevention and management of the adverse effects of cancer and its treatment. This includes management of physical and psychological symptoms and side effects across the continuum of the cancer experience from diagnosis through treatment to post-treatment care.Patients with cancer have unique dermatologic needs since skin toxicities are prevalent and are associated with a high physical burden. With this in mind, the oncology multidisciplinary teams would play a key role by developing standard protocols for implementing the use of dermocosmetics for skin care in all oncology patients.In collaboration with MASCC (Multinational Association of Supportive Care in Cancer) and AFSOS (Association Francophone des Soins Oncologiques de Support), a group of experts, with the support of La Roche Posay, evaluated the role of dermocosmetics in improving patient outcomes and minimizing cancer treatment interruptions. The expert panel also provided general recommendations for initiation and selection of skin care in all oncology patients as well as recommendations for what factors should be considered when using dermocosmetics in specific types of skin toxicities.
La Roche-PosayN°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. Recommended by 90,000 dermatologists worldwide*, La Roche-Posay was created by a pharmacist in 1975. The brand is today present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water, also used at its Thermal Center, the first Dermatology Center in Europe, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin. The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer specifically. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare. Since 2019, the Fondation La Roche-Posay is also committed to improving the life of children with cancer and their families. In 2020, the brand went a step further in its commitment to protect the planet. Besides launching the first eco-designed tubes integrating cardboard, the brand announced a long-term plan to reduce its use of virgin plastic by 70% in 2025. For additional information about La Roche-Posay, visit www.laroche-posay.com. *source: survey on the dermocosmetic market carried out by iqvia and other partners (ipsos, tns) between september 2017 and august 2018 among dermatologists in 62 countries.

Log in